New England Securities’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$12K Sell
256
-465
-64% -$22.6K ﹤0.01% 1038
2014
Q3
$41K Buy
721
+385
+115% +$20.7K 0.01% 674
2014
Q2
$18K Buy
336
+80
+31% +$4.25K 0.01% 948
2014
Q1
$13K Sell
256
-832
-76% -$42.1K 0.01% 991
2013
Q4
$58K Buy
1,088
+138
+15% +$7.12K 0.02% 505
2013
Q3
$48K Buy
950
+186
+24% +$9.46K 0.02% 498
2013
Q2
$39K Buy
+764
New +$40.7K 0.03% 501

Other funds holding SNY

New England Securities's SNY Position: Q4 2014 in Review

New England Securities reduced its Sanofi (SNY) stake by 64% in Q4 2014, selling an estimated $22.6K and leaving 256 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

New England Securities first reported a position in SNY in Q2 2013 and has held it in 7 quarters since. The position peaked at $58K in Q4 2013. 499 funds tracked by Wall St. Rank hold SNY as of Q4 2014.

  • New England Securities held 256 shares of Sanofi worth $12K as of Q4 2014.
  • New England Securities sold 465 Sanofi shares in Q4 2014, an estimated $22.6K.
  • Sanofi made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1038 holding.
  • New England Securities first reported a position in Sanofi in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Sanofi position peaked at $58K in Q4 2013.
  • 499 funds tracked by Wall St. Rank held Sanofi as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.